RxSight (RXST) Gross Profit (2020 - 2026)

RxSight (RXST) has reported Gross Profit for 7 consecutive years, with $23.5 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 17.05% year-over-year to $23.5 million; the trailing twelve-month figure through Mar 2026 stood at $98.2 million (down 7.89% YoY), and the FY2025 full-year result was $103.0 million, up 4.11% from the prior year.
• Gross Profit declined to $23.5 million in Q1 2026 per RXST's latest filing, from $25.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $28.8 million in Q4 2024 and bottomed at $3.8 million in Q1 2022.
• Historically, Gross Profit has averaged $17.7 million across 5 years, with a median of $20.7 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Gross Profit soared 689.66% in 2022, then slipped 17.05% in 2026.
• Over 5 years, Gross Profit stood at $7.4 million in 2022, then soared by 137.86% to $17.7 million in 2023, then jumped by 63.07% to $28.8 million in 2024, then slipped by 12.24% to $25.3 million in 2025, then declined by 6.99% to $23.5 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $23.5 million, $25.3 million, and $24.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.